Antipsychotic Polypharmacy and Metabolic Disorder Risk in Individuals With Schizophrenia

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{5a679678897a4c148bcadd319db923a0,

title = "Antipsychotic Polypharmacy and Metabolic Disorder Risk in Individuals With Schizophrenia",

author = "Brian Miller",

year = "2023",

month = dec,

language = "English (US)",

volume = "40",

journal = "Psychiatric Times",

issn = "0893-2905",

publisher = "Psychiatric Times",

number = "12",

}

TY - JOUR

T1 - Antipsychotic Polypharmacy and Metabolic Disorder Risk in Individuals With Schizophrenia

AU - Miller, Brian

PY - 2023/12

Y1 - 2023/12

UR - https://www.scopus.com/pages/publications/85194459110

UR - https://www.scopus.com/pages/publications/85194459110#tab=citedBy

M3 - Article

AN - SCOPUS:85194459110

SN - 0893-2905

VL - 40

JO - Psychiatric Times

JF - Psychiatric Times

IS - 12

ER -